Search results for: France
Filter search results
Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling
5 November 2014
…to look closely at models of health economic evaluation in France, Germany and the UK. This presentation can be watched here https://www.youtube.com/watch?v=AyoScR9BjuU, from 00:29:27 to 1:28:00. Antibiotics and the…
Biosimilar Competition: Lessons from Europe and Prospects for the US
2 December 2014
…granulocyte-colony-stimulating-factors (G-CSFs) has evolved since 2009 in France, Germany, Italy, Sweden and the UK. The author highlights two key results. Firstly, the market experience varies greatly across product classes…
Recently Published: New Report Comparing Usage of Medicines in the UK with Other Countries
6 January 2015
…of medicines in the UK relative to 12 comparable high-income countries including France, Germany, Italy, Spain and the USA. Sixteen classes of medicines were included in the original Richards report…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). Information regarding NICE HTA recommendations was extracted from NICE’s website and HTAinSite.com, and additional information…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…of 29 drug/indication pairs and a group of 15 countries were studied (Australia, Canada, Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). The…
How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards
24 November 2015
…for how RWD (both routinely-collected and de-novo) is accessed or generated, and used credibly to provide evidence in eight countries: the UK, France, Italy, Sweden, Germany, the Netherlands, Australia and…
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
…with decision makers and experts in eight countries (Australia, France, Germany, Italy, Poland, South Korea, Sweden, and the United Kingdom). We found that in the eight countries examined, with the…
Dr Francois Maignen joins the OHE team as Head of Operational Research and Data Analysis
7 July 2016
…a doctorate in pharmacy, a post-graduation diploma in hospital pharmacy and public health and a MSc in molecular pharmacochemistry, experimental pharmacology and metabolism (Université René Descartes, Paris V, France). Francois…
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…countries (Belgium, Denmark, France, Germany, Italy, the Netherlands, Poland, Sweden, and the UK) as well as the EU27 average. The report highlights that cancer represents a significant disease burden in…